Detection of tryptase-, chymase+ cells in human CD34+ bone marrow progenitors
- 12 November 2004
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 34 (11) , 1719-1724
- https://doi.org/10.1111/j.1365-2222.2004.02105.x
Abstract
Background Mast cells (MCs) arise from haematopoietic stem cells. We have recently reported that CD34+ progenitors derived from human bone marrow (BM) develop into tryptase+, chymase+ MCs when cultured in the presence of recombinant human stem cell factor (rhSCF) and recombinant human IL‐6 (rhIL‐6). In an experiment for the expression of chymase during differentiation, chymase+ cells were detected in human BM, but tryptase+ cells were not found. Objective The purpose of this study was to show the appearance of chymase+ cells in CD34+ cells with an origin different from MC differentiation. Methods CD34+ cells from human BM were sorted with anti‐CD117 monoclonal antibody (mAb), and cytospins of CD34+, CD34+CD117+, or CD34+CD117− were prepared. These cells were cultured with rhSCF+rhIL‐6 for 12 weeks. Some of the cells were subjected to either histological stain with Wright–Giemsa or immunocytochemistry with anti‐chymase mAb. Real‐time RT‐PCR was also performed to compare the transcriptional level of chymase from each cell preparation. Results Chymase was expressed in CD34+ cells as well as human MCs by immunocytochemistry. Substantial CD34+CD117− cells, but not CD34+CD117+ cells, were stained immunocytochemically with anti‐chymase mAb. For 1 week culture with rhSCF+rhIL‐6, no cells expressed chymase in any preparation. Real‐time RT‐PCR revealed positivity for chymase mRNA in CD34+ cells, but it reduced at 1 week of culture, and increased as cells developed into MCs. Chymase mRNA in CD34+CD117+ cells was negligible compared with that in CD34+CD117−. Tryptase mRNA was below the detectable level in CD34+ cells, and increased along with MC differentiation. After 12 weeks of culture, CD34+CD117+ developed predominantly into MCs, whereas CD34+CD117− developed into monocytes/macrophages. Conclusion Our findings suggested that chymase is present not only in MCs but also in CD34+CD117− BM progenitors, but that its origin is different from the MC lineage.Keywords
This publication has 16 references indexed in Scilit:
- Chymase-positive mast cells in small sized adenocarcinoma of the lungVirchows Archiv, 2003
- Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric studyJournal of Clinical Pathology, 2003
- Mast Cell Chymase Modifies Cell-Matrix Interactions and Inhibits Mitogen-Induced Proliferation of Human Airway Smooth Muscle CellsThe Journal of Immunology, 2002
- Characterization of ‘adult‐type’ mast cells derived from human bone marrow CD34+ cells cultured in the presence of stem cell factor and interleukin‐6. Interleukin‐4 is not required for constitutive expression of CD54, FcεRIα and chymase, and CD13 expression is reduced during differentiationClinical and Experimental Allergy, 2002
- Evidence for a Role of Mast Cells in the Evolution to Congestive Heart FailureThe Journal of Experimental Medicine, 2002
- Mast Cell Chymase Inhibits Smooth Muscle Cell Growth and Collagen Expression In VitroArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Regulation of extravascular coagulation and fibrinolysis by heparin‐dependent mast cell chymaseThe FASEB Journal, 2001
- Regulation of chymase production in human mast cell progenitorsJournal of Allergy and Clinical Immunology, 2000
- Cleavage of Type I Procollagen by Human Mast Cell Chymase Initiates Collagen Fibril Formation and Generates a Unique Carboxyl-terminal PropeptideJournal of Biological Chemistry, 1997
- Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies.Journal of Histochemistry & Cytochemistry, 1989